Spontaneous rupture of coronary artery in human immunodeficiency virus-positive patient treated with highly active anti-retroviral therapy (HAART)
De Giorgio, F.; Abbate, A.; Capelli, A.; Arena, V.
American Journal of Forensic Medicine and Pathology 26(2): 197
2005
ISSN/ISBN: 0195-7910 PMID: 15894860 Document Number: 593151
Document emailed within 1 workday
Related Documents
Iduoriyekemwen, N.J.; Sadoh, W.E.; Sadoh, A.E. 2013: Prevalence of renal disease in Nigerian children infected with the human immunodeficiency virus and on highly active anti-retroviral therapy Saudi Journal of Kidney Diseases and Transplantation: An Official Publication of the Saudi Center for Organ Transplantation Saudi Arabia 24(1): 172-177Breuckmann, F.; Neumann, T.; Kondratieva, J.; Wieneke, H.; Ross, B.; Nassenstein, K.; Barkhausen, J.; Kreuter, A.; Brockmeyer, N.; Erbel, R. 2005: Dilated cardiomyopathy in two adult human immunodeficiency positive (HIV+) patients possibly related to highly active antiretroviral therapy (HAART) European Journal of Medical Research 10(9): 395-399
Miiro, G.; Todd, J.; Mpendo, J.; Watera, C.; Munderi, P.; Nakubulwa, S.; Kaddu, I.; Rutebarika, D.; Grosskurth, H. 2009: Reduced morbidity and mortality in the first year after initiating highly active anti-retroviral therapy (HAART) among Ugandan adults Tropical Medicine and International Health: Tm and Ih 14(5): 556-563
Leng, L.K.; Pancharoen, C.; Bunupuradah, T.; Thisyakorn, U.; Trinavarat, P.; Sosothikul, D.; Ananworanich, J. 2007: Regression of a cervical spinal mass following highly active antiretroviral therapy (HAART) in child with advanced human immunodeficiency virus (HIV) disease Journal of the Medical Association of Thailand 90(9): 1937-1942
Ruanjahn, G.; Roberts, D.; Monterosso, L. 2010: An exploration of factors influencing adherence to highly active anti-retroviral therapy (HAART) among people living with HIV/AIDS in Northern Thailand Aids Care 22(12): 1555-1561
Koyanagi, A.; Humphrey, J.H.; Ntozini, R.; Nathoo, K.; Moulton, L.H.; Iliff, P.; Mutasa, K.; Ruff, A.; Ward, B.; Chidawanyika, H.; Hargrove, J.; Mahomva, A.I.; Majo, F.; Malaba, L.C.; Mbizvo, M.T.; Mzengeza, F.; Ndhlovu, M.; Piwoz, E.; Propper, L.; Rambanepasi, P.; Ruff, A.J.; Tavengwa, N.; Zijenah, L.S.; Zunguza, C.D.; Zvandasara, P. 2011: Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy Pediatric Infectious Disease Journal 30(1): 45-51
Villarroya, F.; Domingo, P.; Giralt, M. 2005: Lipodystrophy associated with highly active anti-retroviral therapy for HIV infection: the adipocyte as a target of anti-retroviral-induced mitochondrial toxicity Trends in Pharmacological Sciences 26(2): 88-93
Vibhagool, A.; Sungkanuparph, S.; Mootsikapun, P.; Chetchotisakd, P.; Tansuphaswaswadikul, S.; Bowonwatanuwong, C.; Ingsathit, A. 2003: Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy: a prospective, multicenter, randomized study Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 36(10): 1329-1331
Moy, F.S.; Fahey, P.; Nik Yusoff, N.K.; Razali, K.A.; Nallusamy, R. 2015: Outcomes of human immunodeficiency virus-infected children after anti-retroviral therapy in Malaysia Journal of Paediatrics and Child Health 51(2): 204-208
Kidangazhiayathmana, A. 2011: Is Kerala remaining low prevalent in human immunodeficiency virus by accident? a study of risk factors in acquiring human immunodeficiency virus infection in patients attending Anti-retroviral treatment clinic Indian Journal of Dermatology Venereology and Leprology 77(6): 729
Nguyen, P.A.; Syed-Abdul, S.; Minamareddy, P.; Lee, P.; Ngo, T.D.; Iqbal, U.; Nguyen, P.H.; Jian, W.-S.; Li, Y.-C.J. 2013: A method to manage and share anti-retroviral (ARV) therapy information of human immunodeficiency virus (HIV) patients in Vietnam Computer Methods and Programs in Biomedicine 111(2): 290-299
Chandrasekhar, A.; Gupta, A. 2011: Nutrition and disease progression pre-highly active antiretroviral therapy (HAART) and post-HAART: can good nutrition delay time to HAART and affect response to HAART? American Journal of Clinical Nutrition 94(6): 1703s-1715s
Guo, F.-p.; Yu, X.-b.; Luo, L.; Han, Y.; Qiu, Z.-f.; Zuo, L.-y.; Li, Y.-l.; Yu, W.; Li, T.-s. 2010: The impact of highly active antiretroviral therapy on bone mineral density in human immunodeficiency virus infected patients Zhonghua Nei Ke Za Zhi 49(8): 649-652
Nelwan, E.J. 2014: Adherence to highly active antiretroviral therapy (HAART) in HIV/AIDS patient Acta Medica Indonesiana 46(4): 273-274
Tiwari, B.R.; Karki, S.; Ghimire, P.; Sharma, B.; Malla, S. 2013: Improvement in immunological parameters in patients receiving highly active anti-retroviral therapy in Nepal Japanese Journal of Infectious Diseases 66(3): 252-255
Bedingfield, N.; Kipp, W.; Kaler, A.; Rubaale, T. 2014: Revelations of HIV-infected patients treated with highly active antiretroviral therapy (HAART) in rural Uganda Aids Care 26(1): 75-78
Pomerantz, R.J. 1999: HIV patients receiving HAART therapy can still transmit the virus. Highly active antiretroviral chemotherapy American Family Physician 59(10): 2855
Venkatesh, K.K.; Biswas, J.; Kumarasamy, N. 2008: Impact of highly active antiretroviral therapy on ophthalmic manifestations in human immunodeficiency virus / acquired immune deficiency syndrome Indian Journal of Ophthalmology 56(5): 391-393
Palacios, G.C.; Montalvo, M.S.; Fraire, M.I.; Leon, E.; Alvarez, M.T.; Solorzano, F. 2008: Audiologic and vestibular findings in a sample of human immunodeficiency virus type-1-infected Mexican children under highly active antiretroviral therapy International Journal of Pediatric Otorhinolaryngology 72(11): 1671-1681
Chitra, P.; Bakthavatsalam, B.; Palvannan, T. 2011: Beta-2 microglobulin as an immunological marker to assess the progression of human immunodeficiency virus infected patients on highly active antiretroviral therapy Clinica Chimica Acta; International Journal of Clinical Chemistry 412(11-12): 1151-1154